Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

Weight management goes digital

Weight Watchers is getting into meds, while digital pharmacies like Ro are moving into obesity.

Axios

Robin Abcarian: Could our love affair with sugar and artificial sweeteners literally break our hearts?

I love sugar and, as a kid, I had a lot of cavities.

Los Angeles Times

What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications

“Weight loss may turn back your biological age, but it tends to turn your facial clock forward,” one dermatologist says

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

The Independent UK

The cost of the Ozempic craze

The drug shortage is affecting people with Type 2 diabetes, and a surge in cosmetic use is to blame

Salon

Editorial: What insulin should cost: Eli Lilly comes through for Americans with diabetes

A hearty thank you to Eli Lilly, one of the planet’s top three producers of insulin, for slashing the price of its most widely prescribed form of insulin by 70% while capping related out-of-pocket costs at $35 a month. That means diabetics with private insurance will now pay costs on…

Tribune News Service

One in 10 Thai children obese: Dept

Almost 10% of Thai children are clinically obese, according to a Department of Health study. The report warned the situation is expected to get worse if parents and teachers fail to improve nutritional awareness among the young.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

Yes, England’s new weight-loss drug kills your appetite – but as I know, it comes at a cost

While the medication I take has hugely helped my health, it has also robbed me of the joy I took in food, says critic Leila Latif

The Guardian - UK

Dear Abby: I’m worried friend is mishandling her diabetes and might die

Despite taking insulin, she has moments of becoming unresponsive.

Chicago Sun-Times

Brave Love Island star shares eating disorder hell after being fat-shamed at work

Love Island's Dr Alex George has spoken out about eating disorders and bravely revealed he secretly battled one after being fat-shamed while at work

Daily Mirror

Half of world will be obese by 2035, health organization predicts

Half the world will be overweight by 2035, a health group warns.

Tribune News Service

OPINION - The Leader podcast: Behind the celebrity weight-loss drug semaglutide

There’s always a new fad diet, fitness trend or alleged ‘quick fix’ and the latest one is called semaglutide - also known by brand names Ozempic and Wegovy.

Evening Standard

University of Dundee company MyWay helps Scottish Muslims fast during Ramadan

A UNIVERSITY of Dundee spinout company specialising in diabetes care is helping Muslims with the condition to fast safely during Ramadan.

The National (Scotland)

Half the world's population predicted to be overweight and obese by 2035 if current trends continue

Survey by the World Obesity Federation makes for grim reading if improvements are not made around the globe

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

The New Daily

Half the world will be overweight or obese by 2035, slim support for Australians

More than half of the world's population will be overweight or obese by 2035 without significant action, according to a report.

AAP

Few obese Australians receiving targeted GP support

More than two-thirds of Australian adults are classed as overweight or obese and that figure is projected to increase in coming years.

The Guardian - AU

GPs in community health centres are withering from neglect

Under Medicare, GP clinics that once could provide time and care for the most vulnerable now have to squeeze in as many patients as possible

The Guardian - UK

More than half of humans on track to be overweight or obese by 2035 – report

Campaigners urge ambitious global intervention with 25% of people expected to be clinically obese in 12 years

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

OPINION - I feel sorry for Leonardo DiCaprio, he’ll never experience love like me

When my wife first told me that she thought she might be perimenopausal I was shocked and confused. I demanded to know who the hell this Perry character was and why Bridget was self-identifying as him. It was only when she explained that the perimenopause referred to the time during…

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

ABC News

Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers

The cost of 14-year-old Freya Goldston's diabetes medication will soar next month when it's taken off the Pharmaceutical Benefits Scheme and her family don't know if they'll be able to afford it.

Tribune News Service

Eli Lilly is capping consumer insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

Al Jazeera

US drug maker to slash some insulin prices, expand cost cap

President Joe Biden hails move by Eli Lilly as a ‘big deal’, calling on other manufacturers to also reduce prices.

Chicago Sun-Times

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Lawmakers and patient advocates have been pressuring drugmakers to take action on soaring drug prices.

Tribune News Service

Eli Lilly is capping customers’ insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

1 … 70 71 72 73

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.